Tremfya's Promising Debut Boosts Momentum for IL-23 Class in Ulcerative Colitis Treatment, According to Spherix Global Insights
15 nov. 2024 09h38 HE
|
Spherix Global Insights
EXTON, PA, Nov. 15, 2024 (GLOBE NEWSWIRE) -- In what has been a transformative year for ulcerative colitis (UC) treatment, the IL-23 class has solidified its role as a key therapeutic treatment...
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
16 oct. 2024 08h00 HE
|
Oshi Health
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
US Digestive Health Welcomes Seven New Physicians to Its Practice
15 oct. 2024 10h00 HE
|
US Digestive Health
EXTON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the nation’s largest gastroenterology (GI) practices, today announced the addition of seven new physicians to its...
Exciting Advances in Ulcerative Colitis Treatments: Skyrizi Gains Early Momentum Following FDA Approval in June
01 oct. 2024 10h51 HE
|
Spherix Global Insights
EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have been transformative for the rapidly evolving ulcerative colitis (UC) market, with a surge in advanced therapies receiving FDA...
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 25 000 €. L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies
30 sept. 2024 16h09 HE
|
Biocodex Canada
MONTRÉAL, 30 sept. 2024 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le...
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases
30 sept. 2024 16h09 HE
|
Biocodex Canada
Biocodex Microbiota Foundation offers a €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases.
Gastrointestinal Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 386 Deals Signed Since 2016 by the World's Leading Life Science Companies and Universities
25 sept. 2024 09h15 HE
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated,...
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
25 sept. 2024 08h16 HE
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Compact C-Arm Market to Reach $714.1 Million, Globally, by 2033 at 5.7% CAGR: Allied Market Research
23 sept. 2024 10h56 HE
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Compact C-Arm Market by Technology (Fluoroscopy Systems and Flat Detector Systems),...
Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
23 sept. 2024 10h18 HE
|
Spherix Global Insights
EXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late...